Prurigo pigmentosa with new-onset diabetic ketoacidosis - CMAJ

A 13-year-old, previously healthy, boy presented to the emergency department with a 1-week history of progressive, highly pruritic urticarial erythematous papules and confluent plaques in a symmetric, reticulated distribution on his neck, back and torso (Figure 1). Older lesions were hyperpigmented and squamous.

Photographs of a 13-year-old boy with prurigo pigmentosa, showing erythematous reticulated papules and plaques that are confluent on the (A) back and (B) torso.
" data-icon-position data-hide-link-title="0">Figure 1:
Figure 1:

Photographs of a 13-year-old boy with prurigo pigmentosa, showing erythematous reticulated papules and plaques that are confluent on the (A) back and (B) torso.

The patient reported a progressive, 1-month history of 6 kg weight loss, polydipsia, polyuria, polyphagia and fatigue. Laboratory results showed hyperglycemia, ketonemia, glycosuria and metabolic acidosis, consistent with diabetic ketoacidosis. Our differential diagnoses for the skin lesions were prurigo pigmentosa, contact dermatitis, urticaria, confluent and reticulated papillomatosis (i.e., Gougerot–Carteaud syndrome) and erythema ab igne. We biopsied the skin, which showed subacute spongiosis, with eosinophilic and lymphohistiocytic perivascular infiltrates and papillary edema. We diagnosed prurigo pigmentosa.

As per our local protocol for diabetic ketoacidosis, we prescribed intravenous, then subcutaneous insulin, which led to adequate control of glucose and ketone levels, and improvement of the skin lesions over 3 weeks (Appendix 1, available at www.cmaj.ca/lookup/doi/10.1503/cmaj.210723/tab-related-content).

Prurigo pigmentosa is an inflammatory dermatitis with more than 300 cases reported.1 Its exact cause remains unknown; however, proketogenic states contribute to the pathogenesis, leading to an accumulation of ketone bodies around the blood vessels that may result in dermal perivascular inflammation.1,2

Prurigo pigmentosa has been reported with intense fasting, anorexia nervosa, hyperemesis gravidarum, bariatric surgery, type I diabetes mellitus and, more recently, ketogenic diets.1,3 Risk factors for development or worsening of lesions include dietary changes, friction, sweat, ketonuria and hormonal changes.3 The lesions are pruritic and usually present with erythematous reticulated papules and plaques on the back, chest and neck areas, sparing the face, arms, legs and mucosa. Mottled hyperpigmentation occurs as lesions resolve.1 Diagnosis of prurigo pigmentosa is largely clinical, as histologic findings are nonspecific and can vary depending on the lesions' stages; different stages can coexist. In our patient, histological results were consistent with clinical findings of lesions at different stages. Although not a classic finding, a predominance of eosinophils has been reported with prurigo pigmentosa, and necrotic keratinocytes are not always present.3,4

Treatment is tailored to the cause of the proketogenic states. Specialists may prescribe anti-inflammatory adjunct therapies if symptoms do not resolve, including tetracycline or macrolide antibiotics, isotretinoin, dapsone, colchicine or phototherapy.1

Footnotes

  • Competing interests: None declared.

  • This article has been peer reviewed.

  • The authors have obtained patient consent.

This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/

Adblock test (Why?)

Comments

Post a Comment

Popular posts from this blog

Rashes that look like scabies: Causes, symptoms, and treatment - Medical News Today

Image
Scabies is a skin condition that occurs as the result of a mite known as Sarcoptes scabiei. The rash that results from scabies may appear similar to other skin conditions, such as psoriasis, eczema, or contact dermatitis. In this article, we look at what a scabies rash looks like. We also look at other rashes that are similar in appearance and their treatment options. Scabies is a common condition that occurs as the result of an infestation of a microscopic skin mite called Sarcoptes scabiei. The mites burrow under the skin, causing intense itching and a rash. The Centers for Disease Control and Prevention (CDC) describes the rash as pimple-like. On darker skin, the rash may be more difficult to see, but a person should be able to feel it. According to DermNet, a scabies rash is varied in appearance, and may appear as: pimple-like on the limbs and trunk widespread or coin-shaped small blisters scales lesions in the armpits, groin, navel, areolas, scrotum, buttocks, and along the penil...
Read more

Urinary Tract Infection (UTI): Causes, Symptoms & Treatment - Cleveland Clinic

Image
Can I prevent a urinary tract infection? The following lifestyle changes can help prevent urinary tract infections: Practice good hygiene Practicing good hygiene is one of the best ways to help prevent UTIs. This is especially important if you have a vagina because your urethra is much shorter, and it's easier for E. coli to move from your rectum back into your body. Always wipe from front to back after a bowel movement (pooping) to avoid this. During your menstrual cycle, it's also a good idea to regularly change your period products, including pads and tampons. You should also avoid using any deodorants on your vagina. Drink plenty of fluids Drinking extra fluids — especially water — each day can help flush out bacteria from your urinary tract. Healthcare providers recommend drinking six to eight glasses of water daily. Change your peeing habits Peeing can play a big role in getting rid of bacteria from your body. Your pee is a waste product, and each time you empty your bla...
Read more

Symtuza: Uses, side effects, alternatives, and more - Medical News Today

Image
The Food and Drug Administration (FDA) approves prescription drugs such as Symtuza to treat certain conditions. Symtuza is FDA-approved to treat HIV-1 in adults and children who weigh at least 40 kilograms (kg), which is about 88 pounds (lb). It's approved for people who: have just been diagnosed with HIV and haven't started treatment yet, OR are changing from another HIV treatment and: have been on a stable antiretroviral regimen for at least 6 months (this means you haven't had any changes to your HIV drugs for at least 6 months) have a viral load (the amount of HIV in your blood) that's less than 50 copies per milliliter (mL) have HIV that doesn't have mutations (changes) that could make it resistant (less likely to respond) to darunavir or tenofovir (two of the active drugs in Symtuza) HIV explained HIV stands for human immunodeficiency virus. There are two forms of this virus, HIV-1 and HIV-2. HIV-1 is the most common form. HIV is transmitted through body fluid...
Read more